Search Within
Document Type
220-335-8
Applied Filters:
Keyword:'220-335-8'
Showing 1-26 of 26 results for "220-335-8" within Technical Documents
Bright prospects - Solvents for spectroscopy Uvasol®EMD
(65 %), 220 (80 %),
225 (85 %), 235 (90 %), 245 (98 %),
255 (99 %)
500 ml GL 1.04718.0500
2.5 l GL 1.04718.2500
M Methanol 99.9 0.0002 0.01 1.0 1.0 205
Data Sheet-SCC219
solutions at 2-8 °C, except for the 2nd antibody incubation.
1. Collect the suspension culture. Centrifuge @ 220 x g for 5 minutes. Aspirate.
2. Wash the cell pellet once in 1X PBS. Centrifuge @ 220 x g
NovAseptic Mixer, Drive Unit, GMP
456 169 195 220 75 GMP30000
Specifications
Net Weight (approximate)
Mixer Assembly GMP50 GMP100 GMP500 GMP1000 GMP2000 GMP5000 GMP10000 GMP20000 GMP30000
Weight kg (lb) 8 (17.6) 8 (17.6) 10
XP725 Antibody Number-Lot Number 071M4826
6 309 310 311 312 333 334 335 336 357 358 359 360 381 382 383 384
XP725 Antibody Number—Lot Number 071M4826
A B C D
a-b c-d e-f g-h a-b c-d e-f g-h a-b c-d e-f g-h a-b
Quality Control Range Sheet- A6041-103 and A6041-203
Control 1 123 - 256 pg/mL MCP-1 Control 1 69 - 143 pg/mL
Control 2 636 - 1320 pg/mL Control 2 335 - 695 pg/mL
HPLC Reagents
1.00AU max
UV Abs. at 330 nm ......................................... 0.80AU max
UV Abs. at 335 nm ......................................... 0.30AU max
UV Abs. at 340 nm ......................
Nitrate Spectroquant Test Kits Equivalency Report 2017
1.14542 520
1.14942 499
1.14773 516
1.14556 504
1.01842 500
TNT 835 335
TNT 836 335
Standard Methods
4500-NO3 (E)
537
Solvents Catalog
0.005 0.0002 0.0002 210 (50 %), 220 (80 %),
245 (98 %)
1 I GL 1.04390.1000
Details see page 18 2.5 l GL 1.04390.2500
n-Hexane 98.0 1 0.01 0.0002 0.0002 210 (50 %), 220 (85 %)
White Paper: New Opportunities for Oral Sustained Release Formulations with Polyvinyl Alcohol
Amount
mg/tablet % (w/w)
Internal phase
Ascorbic acid 160 32
Parteck® SRP 80 excipient 335 67
External phase
Silicon dioxide, highly dispersed 2.5 0.5
Parteck® LUB MST
magnesium stearate
Chrombook 2015 - The world of chromatography in your hands
www.emdmillipore.com/analytical-hplc
An
al
yt
ic
al
H
PL
C
220
[min]
0 5.0 7.0
1
2 3
4
5
6
7
8
Chromolith® RP-18
TB163 Ek/LIC Cloning Kits
(2003) inNovations 18, 7–12.
8. Rodems, S. M. and Friesen, P. D. (1993) J. Virol. 67, 5776–5785.
9. Guarino, L. A. and Dong, W. (1994) Virology 200, 328–335.
10. Pullen, S.
Disks and Strips for Microbiology
of Media
and Reagents for Indole-Spot Test in Anaerobic
Bacteriology., Am. J. Clin. Pathol., 58, 335 (1972)
3. G.D. Fay, A.L. Barry, Methods for Detecting Indole
Production by Gram-negative Non-Spore
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
profiles in acute human babesiosis. American Journal of
Tropical Medicine and Hygiene. 1998; 58(3):335–7. PMID: 9546414
67. Yan XJ, Dozmorov I, Li WT, Yancopoulos S, Sison C, Centola M, et al. Identification
XP725 Antibody List Lot 089K4791
A1226 55742 PARVA P NP_060692.2 y n/d n/d
560 Pen-2 P5622 55851 PSENEN P NP_758844.1 y n/d n/d
335 HDAC-8 H6412 55869 HDAC8 M NP_001159890.1 , y n/d n/d
523 p115/TAP P3118 56042 Uso1 M NP_062252.1 n/d
XP725 Antibody List Lot 129K4831
A1226 55742 PARVA P NP_060692.2 y n/d n/d
560 Pen-2 P5622 55851 PSENEN P NP_758844.1 y n/d n/d
335 HDAC-8 H6412 55869 HDAC8 M NP_001159890.1 , y n/d n/d
523 p115/TAP P3118 56042 Uso1 M NP_062252.1 n/d
XP725 Antibody List Lot 129K4830
A1226 55742 PARVA P NP_060692.2 y n/d n/d
560 Pen-2 P5622 55851 PSENEN P NP_758844.1 y n/d n/d
335 HDAC-8 H6412 55869 HDAC8 M NP_001159890.1 , y n/d n/d
523 p115/TAP P3118 56042 Uso1 M NP_062252.1 n/d
List of Antibodies
-5 H8163 P y y y
332 HDAC-6 H2287 P y y n/d
333 HDAC-7 H2537 P y y y
334 HDAC-7 H6663 M y y n/d
335 HDAC-8 H6412 M y n/d n/d
336 Anti Cy3+Cy5 C0992 M NA NA NA
337 HDAC-10 H3413 P
XP725 Worksheet for Lot Number 071M4826
328 2 3 5 8 Chk1 C9358
329 2 3 6 1 Chk2 C9108
330 2 3 6 2 Chk2 C9108
331 2 3 6 3 Chk2 C9233
332 2 3 6 4 Chk2 C9233
333 2 3 6 5 Chondroitin Sulfate C8035
334 2 3
XP725 Antibody List
T 3
3 9
3 9
334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n/d
335 HDAC-8 H6412 55869 HDAC8 NP_060956.1 M y n/d n/d
336 Anti Cy3+Cy5
337 HDAC-10 H3413 362981, 83933, 170787
XP725 Antibody List 013M4793
_057680.3 P y y y
334 HDAC-7 H6663 56233, 51564 HDAC7A,Hdac7a NP_062518.2,NP_057680.3 M y y n/d
335 HDAC-8 H6412 55869 HDAC8 NP_060956.1 M y n/d n/d
336 Anti Cy3+Cy5 C0992
337 HDAC-10 H3413 362981, 83933
3D BIOPRINTING: Printing a Brighter Future
Biofabrication 2017,
9, 034104.
(51) Nam, S. Y.; Park, S.-H. Adv. Exp. Med. Biol. 2018, 1064, 335.
(52) Lee, H.; Han, W.; Kim, H.; Ha, D.-H.; Jang, J.; Kim, B. S.; Cho, D.-W.
Biomacromolecules
3D BIOPRINTING: Printing a Brighter Future
Biofabrication 2017,
9, 034104.
(51) Nam, S. Y.; Park, S.-H. Adv. Exp. Med. Biol. 2018, 1064, 335.
(52) Lee, H.; Han, W.; Kim, H.; Ha, D.-H.; Jang, J.; Kim, B. S.; Cho, D.-W.
Biomacromolecules
Material Matters Volume 15 number 2 Batteries & Solar Cells
, S.; Friesen, A.;
Niehoff, P.; Nowak, S.; Winter, M.; Schappacher, F. M. J. Power Sources
2016, 335, 45.
(12) Wang, D.; Belharouak, I.; Koenig, G. M.; Zhou, G.; Amine, K. J. Mater.
Chem. 2011, 21
Inhibitor Sourcebook 3rd Edition
14, 5171.
6. Wilkinson, S.E., at al. 1993. Biochem. J. 294, 335.
7. Gschwendt, M., et al. 1994. Biochem. Biophys. Res. Commun. 199, 93.
8. Seynaeve, C.M., et al. 1994. Mol. Pharmacol. 45, 1207.
Halal Certificate
, FCC, FG W202606 B87203 HC-22SI1E81
334. ALLYL DISULFIDE 80%, FG W202800 A99044 HC-22SI4V35
335. ALLYL HEPTANOATE 97%, FCC, FG W203106 B65198 HC-22SILP21
336. Allyl Heptanoate Natural W203111
Halal Certificate
, FCC, FG W202606 B87203 HC-24SI3F83
334. ALLYL DISULFIDE 80%, FG W202800 A99044 HC-24SI7737
335. ALLYL HEPTANOATE 97%, FCC, FG W203106 B65198 HC-24SIAW23
336. Allyl Heptanoate Natural W203111